Skip to main content
OpenTrials

Clinical trial condition

Unspecified Childhood Solid Tumor, Protocol Specific

Explore clinical trials studying Unspecified Childhood Solid Tumor, Protocol Specific. Study availability and eligibility vary by location and protocol.

100 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Unspecified Childhood Solid Tumor, Protocol Specific trial results

Completed

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

NCT00008424

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 51 locations
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

NCT00880282

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

NCT01141244

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
View all 25 locations
View Trial Details
Completed

Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

NCT00112996

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +4 more
Locations
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • CCOP - Wichita Wichita, Kansas, United States
  • Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital Alexandria, Louisiana, United States
View all 13 locations
View Trial Details
Completed

Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors

NCT00622414

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

NCT00006463

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 47 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

NCT00006095

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 22 locations
View Trial Details
Completed

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

NCT00070473

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
View all 20 locations
View Trial Details

Related conditions